retatrutide triple agonist weight loss trial Eli Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial loss. Read about the work via the link in the comments Eli Lilly's triple agonist, retatrutide,

If you feel nauseated, ginger in any form, tea, candied, supplements, helps

We were interested in studying the effect of GLP-1 receptor agonists in uveitis, which is fundamentally an inflammatory eye disease, says Nitesh Mohan, a student at Cleveland Clinic Lerner College of Medicine who was lead author of the study

For other individuals, however, the benefits of improved glycemic control, weight loss, and cardiovascular risk reduction may outweigh theoretical concerns

For someone starting at 165 lbs, that represents approximately 40 lbs of fat loss

Take your supplements, including any vitamins recommended for GLP-1 users

Weeks 1 through 4 (initiation phase): Starting dose once daily